{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:35:48Z","timestamp":1787884548779,"version":"build-2784847793"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key R&amp;D Program of China","award":["No.2017YFC0113000 and 2017YFC0113005"],"award-info":[{"award-number":["No.2017YFC0113000 and 2017YFC0113005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The protective role of serum total bilirubin, a widely recognized antioxidant, has been approved by numerous updating studies. However, regarding the effect of high serum total bilirubin level (STBL) in arteriosclerotic cardiovascular disease (ASCVD) are conflicting in different sources of data. We, therefore, performed this meta-analysis to evaluate the influence of STBL on risk of ASCVD.<\/jats:p>\n            <jats:p>Four databases were used to identify the literature with a date of search of January, 2019. Finally, a total of 20 studies had been adopted. ASCVD was defined as acute coronary syndrome, stable angina, coronary revascularization, atherosclerotic stroke or transient ischemic attack, and peripheral arterial disease (PAD). All relevant data were collected from studies meeting the inclusion criteria.<\/jats:p>\n            <jats:p>A total of 20 published studies (323,891 cases) met the inclusion criteria. The meta-analysis revealed that, in studies excluding heterogeneity, STBL was significantly positively related to in-hospital cardiovascular mortality (odds ratio [OR] 2.82, 95% confidence interval [CI] 1.83\u20134.36, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u200a=\u200a4.69, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and major adverse cardiac events (OR 1.88, 95% CI 1.414\u20132.491, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u200a=\u200a4.36, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), also negatively associated with prognosis of acute myocardial infarction, pooled hazard ratio (HR)\u200a=\u200a0.804 (95% CI 0.700\u20130.923, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u200a=\u200a3.08, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002). The correlation similarity was also reflected in terms of patients with stroke (HR 0.78, 95% CI 0.70\u20130.88, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u200a=\u200a4.24, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003). Combined analysis revealed that lower STBL was significantly associated with PAD, pooled OR\u200a=\u200a0.91 (95% CI 0.85\u20130.98, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u200a=\u200a2.39, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.017). In general analysis, a conclusion can be drawn, that higher STBL was significantly negative correlated with cardiovascular disease, pooled HR\u200a=\u200a0.83 (95% CI 0.73\u20130.94, Z\u200a=\u200a3.02, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003).<\/jats:p>\n            <jats:p>Higher STBL significantly improved the prognosis of ASCVD; furthermore, STBL was an important factor in the long-term prognosis of vascular-related disease prevention and can be used as a predictor in vascular-related disease risk prediction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017544","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:17:50Z","timestamp":1571303870000},"page":"e17544","source":"Crossref","is-referenced-by-count":30,"title":["Is serum total bilirubin a predictor of prognosis in arteriosclerotic cardiovascular disease? A meta-analysis"],"prefix":"10.1097","volume":"98","author":[{"given":"Yang","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","article-title":"Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the Global Burden of Disease Study 2013","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet (London, England)"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"(Pt B)","key":"R3-20230915","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013\u200aACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/01.ATV.0000163846.51473.09","article-title":"Oxidative enzymopathies and vascular disease","volume":"25","author":"Leopold","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1253\/circj.CJ-15-1397","article-title":"Initial total bilirubin and clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents","volume":"80","author":"Chung","year":"2016","journal-title":"Circ J"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cca.2016.12.020","article-title":"The correlation between serum total bilirubin and outcomes in patients with different subtypes of coronary artery disease","volume":"465","author":"Huang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12012-017-9405-3","article-title":"Association of fasting serum bilirubin levels with clinical outcomes after percutaneous coronary intervention: a prospective study","volume":"17","author":"Zhang","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.107.153262","article-title":"Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004","volume":"28","author":"Perlstein","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdiacomp.2016.08.023","article-title":"Elevated serum total bilirubin levels are negatively associated with major diabetic complications among Chinese senile diabetic patients","volume":"31","author":"Liu","year":"2017","journal-title":"J Diabetes Complications"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13340-017-0337-8","article-title":"Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease","volume":"9","author":"Nishimura","year":"2018","journal-title":"Diabetol Int"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2017.11.013","article-title":"High serum bilirubin is associated with lower prevalence of peripheral arterial disease among cardiac patients","volume":"476","author":"Ozeki","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00392-014-0697-z","article-title":"Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study","volume":"103","author":"Mahabadi","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.exger.2015.09.014","article-title":"Serum total bilirubin levels and coronary heart disease--causal association or epiphenomenon?","volume":"72","author":"Kunutsor","year":"2015","journal-title":"Exp Gerontol"},{"key":"R16-20230915","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007792","article-title":"Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (veterans aging cohort study)","volume":"7","author":"Marconi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1161\/STROKEAHA.109.560649","article-title":"Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women","volume":"40","author":"Kimm","year":"2009","journal-title":"Stroke"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1159\/000319778","article-title":"Bilirubin and UGT1A1\u221728 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting","volume":"30","author":"Ekblom","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1179\/1743132815Y.0000000038","article-title":"Is serum total bilirubin useful to differentiate cardioembolic stroke from other stroke subtypes?","volume":"37","author":"Lin","year":"2015","journal-title":"Neurol Res"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.amjcard.2012.09.011","article-title":"Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention","volume":"111","author":"Gul","year":"2013","journal-title":"Am J Cardiol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0003319712474948","article-title":"Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI","volume":"65","author":"Celik","year":"2014","journal-title":"Angiology"},{"key":"R22-20230915","first-page":"15930","article-title":"Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention","volume":"8","author":"Yao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0003319715589246","article-title":"Comparison of serum uric acid, bilirubin, and C-reactive protein as prognostic biomarkers of in-hospital MACE between women and men with ST-segment elevation myocardial infarction","volume":"67","author":"Baumann","year":"2016","journal-title":"Angiology"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00592-016-0946-x","article-title":"Serum bilirubin concentrations and incident coronary heart disease risk among patients with type 2 diabetes: the Dongfeng-Tongji cohort","volume":"54","author":"Wang","year":"2017","journal-title":"Acta Diabetol"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjcard.2019.01.019","article-title":"Relation of direct, indirect, and total bilirubin to adverse long-term outcomes among patients with acute coronary syndrome","volume":"123","author":"Xu","year":"2019","journal-title":"Am J Cardiol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin Chem"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentration of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin Chem"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"e13920","DOI":"10.1097\/MD.0000000000013920","article-title":"Prognostic value of total bilirubin in patients with acute myocardial infarction: a meta-analysis","volume":"98","author":"Shen","year":"2019","journal-title":"Medicine"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/SMJ.0b013e3181eac06a","article-title":"Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation","volume":"103","author":"Okuhara","year":"2010","journal-title":"South Med J"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/STROKEAHA.116.015083","article-title":"Bilirubin and stroke risk using a mendelian randomization design","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ahg.12179","article-title":"Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults","volume":"81","author":"Chiddarwar","year":"2017","journal-title":"Ann Hum Genet"},{"key":"R32-20230915","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004820","article-title":"Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling","volume":"6","author":"Vogel","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2015.05.031","article-title":"Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein\/lipid oxidation in physiologically relevant hyperbilirubinemic serum","volume":"86","author":"Boon","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2015.02.051","article-title":"Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation","volume":"240","author":"Akboga","year":"2015","journal-title":"Atherosclerosis"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20080540","article-title":"Complement activation and disease: protective effects of hyperbilirubinaemia","volume":"118","author":"Basiglio","year":"2009","journal-title":"Clin Sci"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0925-4439(96)00039-7","article-title":"Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes","volume":"1317","author":"Haga","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20120661","article-title":"Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome","volume":"125","author":"Wallner","year":"2013","journal-title":"Clin Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:21:09Z","timestamp":1694812869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017544","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}